Selected-
Han BK, Kuzin I, Gaughan JP, Olsen NJ, Bottaro A. Baseline CXCL10 and CXCL13 levels are Predictive biomarkers for Tumor Necrosis Factor Inhibitor therapy in Patients with moderate to severe Rheumatoid Arthritis: A Pilot, Prospective Study. Arthritis Res Ther. 2016 Apr 22;18(1):93.
Han BK, Olsen NJ, Bottaro A. The CD27-CD70 pathway and Pathogenesis of Autoimmune Disease. Semin Arthritis Rheum. 2016 Feb;45(4):496-501
Becker A, Dao K, Han BK, Kornu R, Lakhanpal S, Mobley A, Li Q, Lian Y, Wu T, Reimold A, Olsen N, Karp D, Chowdhury F, Farrar J, Satterthwaite A, Mohan C, Lipsky P, Wakeland E, Davis L. SLE Peripheral Blood B Cell, T Cell and Myeloid Cell Transcriptomes Display Unique Profiles and Each Subset Contributes to the Interferon Signature. PLoS ONE. 2013; 8(6): e67003
Han BK, Bhatia R, Traisak P, Milcarek B, Hunter K, Schorr C, Eid H, Feinstein D, Cronin P, Kolasinski SL. Clinical Presentations and Outcomes of Systemic Lupus Erythematosus Patients with Infection admitted to Intensive Care Unit. Lupus. 2013;22(7):690-6
Han BK, Yachoui R, Yi K. Are Ocular Complications of a High dose Glucocorticoid treatment Appropriately Monitored in Patients with Rheumatic diseases? Rheumatol Int. 2013;33(11):2951-2
Bennett R, Friend R, Jones K, Ward R, Han BK, Ross R. Revised Fibromyalgia Impact Questionnaire (FIQR): Validation and Properties. Arthritis Res Ther. 2009; 11(4):R120
Han BK, White A, Dao K, Karp D, Wakeland E, Davis L. Increased Prevalence of Activated CD70+CD4+ T Cells in the Periphery of Patients with Systemic Lupus Erythematosus. Lupus. 2005; 14(8): 598-606
Printer-friendly